Technology Transfer

The Technology Transfer, sitting at the AO Innovation Translation Center (AO ITC), advances innovation to improve patient care and surgeon education in musculoskeletal disorders, by translating in-house and external technologies from bench to bedside.

Responsible for the funding streams of the Development Incubator and Strategy Fund, the Technology Transfer is your one-stop shop providing multiyear investments as well as support to secure intellectual property, develop regulatory strategies, gain access to manufacturers, and connect you with the largest network of trauma and orthopedic health care professionals in the world.

The AO funds innovation in a number of ways

Focusing on

Strategy Fund seed funding aimed for innovative products, services, and technologies improving surgeon education or any element of the entire patient journey in musculoskeletal disorders


Early stage idea?


Development Incubator to support inventors from proof of concept to clinical implementation, mentored by an independent board with expertise in R&D, financing, clinical validation, manufacturing, and industrialization


Developing solutions toward clinical implementation?


You might also be interested in

Clinical Evidence

AO ITC clinical research to global standards (ISO 14155 and ICH GCP), drawing on in-house medical and scientific expertise.

AO Technical Commission

Central to the AO ITC's development and valorization of innovations in trauma, spine, craniomaxillofacial, and veterinary surgery.

Innovation Translation Center

Innovation translation at the AO involves developing disruptive technologies to address unmet clinical needs.

"As part of the AO Innovation Translation Center, the Technology Transfer office offers an opportunity for inventors to take vital steps toward applying their ideas to advance patient care."

Michael Schütz, Chair, Technology Transfer Board, AO ITC